Description: The RPA-2.10 monoclonal antibody reacts with human CD2, a 50 kDa cell surface receptor expressed by a majority of thymocytes, all mature T cells and a subset of NK cells. CD2 is a ligand for CD58 in humans and is involved in adhesion and activation of T cells.